Research Areas
| 3 min read
Beckman Coulter acquires asset portfolio and IP comprising nanofluidic handling and detection assets, inventory, patents and trademarks.
| 2 min read
Company looks to tap into the growing U.S. market.
| 2 min read
| 2 min read
Exiqon will develop and manufacture microRNA products on behalf of the Luminex Bioscience Group, based on Luminex’s xMAP technology and Exiqon’s Locked Nucleic Acid technology.
| 3 min read
| 2 min read
Agreement also provides StemCells with access to STC’s intellectual property portfolio for use in drug discovery, screening and testing, and therapeutic use of cellular compositions.
| 2 min read
Picks up Applied Imaging's large portfolio of automated imaging and image analysis systems for $18.3 million.
| 2 min read
Popular Topics
Multimedia
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.
